Form 13-F position report

ASENSUS SURGICAL INC COM (DE)

Reported by MORGAN STANLEY

ASXC CUSIP 04367G103 Manager CIK 0000895421

Reported 117,261 shares, down 66,556 (36.2%) from the prior quarter.

Reported value -54.0%; share count -36.2% vs. the prior quarter.

Reduced
% of reported 13F value < 0.01% This manager · Q1 2024
Shares 117,261 Quarter-end amount reported
Reported value $26,970 Fair value at quarter end
Consecutive quarters held 13 Through Q1 2024

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-09-30 3799000
2021-12-31 2029000
2022-03-31 1077000
2022-06-30 260000
2022-09-30 186000
2022-12-31 146058
2023-03-31 84981
2023-06-30 71779
2023-09-30 55026
2023-12-31 58619
2024-03-31 26970
2024-06-30 33317
2024-09-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

13 quarters
Quarterly reported position history for ASENSUS SURGICAL INC COM (DE) held by MORGAN STANLEY.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2024 Reduced 0 -100,053 (-100.0%) 0 $0 2024-11-14
Q2 2024 Reduced 100,053 -17,208 (-14.7%) < 0.01% $33,317 2024-08-14
Q1 2024 Reduced 117,261 -66,556 (-36.2%) < 0.01% $26,970 2024-05-15
Q4 2023 Reduced 183,817 -19,983 (-9.8%) < 0.01% $58,619 2024-02-13
Q3 2023 Added 203,800 +61,663 (43.4%) < 0.01% $55,026 2023-11-15
Q2 2023 Added 142,137 +12,987 (10.1%) < 0.01% $71,779 2023-08-14
Q1 2023 Reduced 129,150 -291,647 (-69.3%) < 0.01% $84,981 2023-05-15
Q4 2022 Added 420,797 +5,965 (1.4%) < 0.01% $146,058 2023-02-14
Q3 2022 Reduced 414,832 -238,411 (-36.5%) < 0.01% $186,000 2022-11-14
Q2 2022 Reduced 653,243 -1,064,156 (-62.0%) < 0.01% $260,000 2022-08-15
Q1 2022 Reduced 1,717,399 -110,841 (-6.1%) < 0.01% $1,077,000 2022-05-13
Q4 2021 Reduced 1,828,240 -225,514 (-11.0%) < 0.01% $2,029,000 2022-02-14
Q3 2021 Added 2,053,754 +1,098,253 (114.9%) < 0.01% $3,799,000 2021-11-15
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

86 managers reported ASENSUS SURGICAL INC COM (DE) for Q1 2024.

Managers reporting ASENSUS SURGICAL INC COM (DE) in Q1 2024.
Manager Activity Shares Change % of reported 13F Reported value Tenure
VANGUARD GROUP INC Added 11,588,282 +1,122 < 0.01% $2,665,305 13 qtrs
BlackRock Inc Added 3,467,618 +477 < 0.01% $797,553 13 qtrs
GEODE CAPITAL MANAGEMENT LLC Unchanged 2,399,429 0 < 0.01% $552,024 13 qtrs
MASTERS CAPITAL MANAGEMENT LLC Unchanged 2,000,000 0 0.02% $460,000 5 qtrs
STATE STREET CORPORATION Reduced 901,129 -51,800 < 0.01% $207,260 13 qtrs
UBS Group AG Reduced 685,900 -11,057 < 0.01% $157,757 13 qtrs
NORTHERN TRUST CORPORATION Added 572,478 +77,101 < 0.01% $131,670 13 qtrs
ADVISOR GROUP HOLDINGS INC Reduced 281,367 -332 < 0.01% $64,711 13 qtrs
JANE STREET GROUP LLC Added 269,012 +221,372 < 0.01% $61,873 2 qtrs
AlphaCentric Advisors LLC Reduced 250,000 -50,000 0.03% $57,500 5 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
March 31, 2024
Filed
May 15, 2024
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
107,761
Shared
0
None
9,500

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.